Publisher
Springer International Publishing
Reference58 articles.
1. Li Y, Palmisano M, Sun D, Zhou S (2020) Pharmacokinetic disposition difference between cyclosporine and voclosporin drives their distinct efficacy and safety profiles in clinical studies. Clin Pharmacol 12:83–96
2. Germano V, Picchianti Diamanti A, Ferlito C, Podestà E, Salemi S, Migliore A et al (2011) Cyclosporine A in the long-term management of systemic lupus erythematosus. J Biol Regul Homeost Agents 25(3):397–403
3. Mok CC, Ho LY, Ying SKY, Leung MC, To CH, Ng WL (2020) Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis. Ann Rheum Dis 79(8):1070–1076
4. Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z et al (2015) Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann Intern Med 162(1):18–26
5. Zhang H, Liu Z, Zhou M, Chen J, Xing C, Lin H et al (2017) Multitarget therapy for maintenance treatment of lupus nephritis. J Am Soc Nephrol 28(12):3671–3678